Supplementary Figure from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response Article Swipe
Related Concepts
Organoid
Biomarker
Pancreatic cancer
Precision medicine
Predictive value
Medicine
Oncology
Internal medicine
Cancer
Pathology
Biology
Neuroscience
Biochemistry
Toni T. Seppälä
,
Jacquelyn W. Zimmerman
,
Reecha Suri
,
Haley Zlomke
,
Gabriel D. Ivey
,
Annamária Szabolcs
,
Christopher R. Shubert
,
John L. Cameron
,
William R. Burns
,
Kelly J. Lafaro
,
Jin He
,
Christopher L. Wolfgang
,
Ying Zou
,
Lei Zheng
,
David A. Tuveson
,
James R. Eshlemann
,
David P. Ryan
,
Alec C. Kimmelman
,
Theodore S. Hong
,
David T. Ting
,
Elizabeth M. Jaffee
,
Richard A. Burkhart
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22488269.v1
· OA: W4361941585
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22488269.v1
· OA: W4361941585
Supplementary Figure from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Related Topics
Finding more related topics…